The purpose of this study is to determine whether cryotherapy is effective in the treatment of persistent high grade dysplasia (HGD) or early esophageal adenocarcinoma (IMCA) in patients who have not responded to radiofrequency ablation (RFA).
Study Type
OBSERVATIONAL
Enrollment
15
Mayo Clinic
Rochester, Minnesota, United States
Response
To assess efficacy of achieving elimination of dysplasia in patients with RFA-refractory BE with HGD or IMCA
Time frame: 2 years
Predictors of response
To identify potential predictors of CE-D and CE-IM in patients requiring rescue CSA treatment after failed RFA therapy
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.